MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Knowledge, Attitude and Practices about Movement Disorders in India

B. Shetty, S. Mittal, P. Kukkle (Bangalore, India)

Meeting: 2019 International Congress

Abstract Number: 1835

Keywords: Botulinum toxin: Clinical applications: other, Dystonia: Treatment, Parkinsonism

Session Information

Date: Wednesday, September 25, 2019

Session Title: Epidemiology

Session Time: 1:15pm-2:45pm

Location: Les Muses, Level 3

Objective: To understand the Knowledge about various Movement Disorders (MD) in general public and in various Movement Disorder Patients subgroups

Background: The incidence of movement disorders (MD)has been increasing over the years, however, understanding about the same in various population subgroups is unknown.

Method: An electronic based standard questionnaire was used to understand the awareness about the MD.  The questionnaire was divided into various sections to specifically target general public, health care professionals, newly diagnosed Parkinson’s disease patients(<1yr), Parkinson’s disease patients already on treatment and other MD patients.  Subjects were asked specific questions in each subsection to understand their awareness about the disorders, and treatment options.

Results: In total 121 subjects (M:F-67:53) responded to the questionnaire. 96.6% of the subjects had some formal education. In relation to the general awareness about MD, only 48% could recognize that ‘Tremors disorders’ are treated by the MD sub-specialist and 46.8% could recognize other MD. In relation to understanding of therapeutic options, 52.6% respondents were not aware of the use of botulinum toxin by MDS. Most of the newly diagnosed PD (83.3%) were aware that quality of life can be improved with treatment and about 70% acknowledging the awareness of non-motor symptoms in PD. However, majority of them (71.4%) did not know about DBS.  In relation to PD patients, who were on regular treatment for more than a year, good compliance of medications was noted in 72.2% of patients with acknowledgment of progression as explained in their initial consults. 82.3% of patients informed a subjective feel of more than 50% improvement in symptoms. Even in this subgroup only 16.7% acknowledged that DBS is an important therapeutic option during the course of PD though most of them didn’t know when the best time for the surgery is.  In patients with non-Parkinsonism MD, half of them were not aware of their working diagnosis but felt satisfactorily improved with therapy.

Conclusion: Awareness about various MD is varied in different subpopulations and even among the patients who are on regular follow up, the awareness about the treatment and diagnosis was limited.   The above study shows that there is dire need to have different modes of counselling and repeated counselling for patients to make sure that they are in-sync with prognosis and treatment options.

To cite this abstract in AMA style:

B. Shetty, S. Mittal, P. Kukkle. Knowledge, Attitude and Practices about Movement Disorders in India [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/knowledge-attitude-and-practices-about-movement-disorders-in-india/. Accessed July 1, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/knowledge-attitude-and-practices-about-movement-disorders-in-india/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley